Dentsply Sirona Inc. (XRAY): Price and Financial Metrics
GET POWR RATINGS... FREE!
XRAY POWR Grades
- XRAY scores best on the Value dimension, with a Value rank ahead of 81.43% of US stocks.
- The strongest trend for XRAY is in Quality, which has been heading down over the past 179 days.
- XRAY ranks lowest in Sentiment; there it ranks in the 3rd percentile.
XRAY Stock Summary
- DENTSPLY SIRONA INC's market capitalization of $6,735,338,507 is ahead of 79.9% of US-listed equities.
- DENTSPLY SIRONA INC's stock had its IPO on April 25, 1991, making it an older stock than 85.31% of US equities in our set.
- Over the past twelve months, XRAY has reported earnings growth of -260.8%, putting it ahead of just 6.19% of US stocks in our set.
- Stocks that are quantitatively similar to XRAY, based on their financial statements, market capitalization, and price volatility, are XRX, AOUT, TG, SATS, and TRVG.
- Visit XRAY's SEC page to see the company's official filings. To visit the company's web site, go to www.dentsplysirona.com.
XRAY Valuation Summary
- In comparison to the median Healthcare stock, XRAY's price/earnings ratio is 28.41% lower, now standing at 16.
- Over the past 243 months, XRAY's EV/EBIT ratio has gone down 2.1.
Below are key valuation metrics over time for XRAY.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| XRAY | 2022-11-01 | 1.6 | 1.3 | 16.0 | 14.1 |
| XRAY | 2022-10-31 | 1.6 | 1.3 | 15.9 | 14.0 |
| XRAY | 2022-10-28 | 1.6 | 1.3 | 15.9 | 14.0 |
| XRAY | 2022-10-27 | 1.6 | 1.3 | 15.8 | 13.9 |
| XRAY | 2022-10-26 | 1.6 | 1.3 | 16.0 | 14.0 |
| XRAY | 2022-10-25 | 1.6 | 1.3 | 15.7 | 13.8 |
XRAY Growth Metrics
- Its 2 year revenue growth rate is now at 4.49%.
- The 3 year revenue growth rate now stands at 3.99%.
- The 4 year net cashflow from operations growth rate now stands at 5.22%.
The table below shows XRAY's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-06-30 | 4,135 | 660 | 345 |
| 2021-12-31 | 4,251 | 657 | 421 |
| 2021-09-30 | 4,245.3 | 698.5 | 417.5 |
| 2021-06-30 | 4,071.1 | 733.6 | 368.3 |
| 2021-03-31 | 3,494.7 | 694.7 | 173.9 |
| 2020-12-31 | 3,342 | 635 | -83 |
XRAY's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- XRAY has a Quality Grade of C, ranking ahead of 67.88% of graded US stocks.
- XRAY's asset turnover comes in at 0.443 -- ranking 108th of 186 Medical Equipment stocks.
- ZBH, PEN, and IVC are the stocks whose asset turnover ratios are most correlated with XRAY.
The table below shows XRAY's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.443 | 0.538 | 0.150 |
| 2021-03-31 | 0.389 | 0.506 | 0.077 |
| 2020-12-31 | 0.383 | 0.496 | -0.003 |
| 2020-09-30 | 0.395 | 0.503 | -0.002 |
| 2020-06-30 | 0.409 | 0.514 | 0.008 |
| 2020-03-31 | 0.471 | 0.539 | 0.058 |
XRAY Price Target
For more insight on analysts targets of XRAY, see our XRAY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $73.17 | Average Broker Recommendation | 1.54 (Moderate Buy) |
XRAY Stock Price Chart Interactive Chart >
XRAY Price/Volume Stats
| Current price | $31.48 | 52-week high | $58.70 |
| Prev. close | $30.98 | 52-week low | $26.48 |
| Day low | $30.68 | Volume | 614,300 |
| Day high | $31.57 | Avg. volume | 2,250,012 |
| 50-day MA | $29.73 | Dividend yield | 1.59% |
| 200-day MA | $38.34 | Market Cap | 6.77B |
Dentsply Sirona Inc. (XRAY) Company Bio
Dentsply Sirona is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million. (Source:Wikipedia)
Latest XRAY News From Around the Web
Below are the latest news stories about DENTSPLY SIRONA INC that investors may wish to consider to help them evaluate XRAY as an investment opportunity.
Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY) and GlycoMimetics (GLYC)There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on DENTSPLY SIRONA (XRAY – Research Report) and GlycoMimetics (GLYC – Research Report) with bullish sentiments. DENTSPLY SIRONA (XRAY) In a report released today, Brandon Couillard from Jefferies maintained a Buy rating on DENTSPLY SIRONA, with a price target of $37.00. The company's shares closed last Friday at $31.13, close to its 52-week low of $26.48. |
Analysts Are Neutral on Top Healthcare Stocks: DENTSPLY SIRONA (XRAY), Evotec AG (EVO)Analysts fell to the sidelines weighing in on DENTSPLY SIRONA (XRAY – Research Report) and Evotec AG (EVO – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks. DENTSPLY SIRONA (XRAY) In a report released today, Nathan Rich from Goldman Sachs maintained a Hold rating on DENTSPLY SIRONA, with a price target of $34.00. The company's shares closed last Wednesday at $31.11, close to its 52-week low of $26.48. According to TipRanks. |
Barrington Sticks to Their Buy Rating for DENTSPLY SIRONA (XRAY)Barrington analyst Michael Petusky maintained a Buy rating on DENTSPLY SIRONA (XRAY - Research Report) today and set a price target of $40.00. The company's shares closed yesterday at $30.35.According to TipRanks, Petusky is a 4-star analyst with an average return of 7.0% and a 49.71% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Anika Therapeutics, Henry Schein, and Landec.In addition to Barrington, DENTSPLY SIRONA also received a Buy from Morgan Stanley's Erin Wright in a report issued yesterday. However, on the same day, Piper Sandler maintained a Hold rating on DENTSPLY SIRONA (NASDAQ: XRAY). |
Dentsply gains on activist speculation amid 13F filingDentsply Sirona (XRAY) rose 3.7% on speculation of a potential activist investor following a Morgan Stanley 13F filing.Morgan Stanley was the second biggest buyer of Dentsply (XRAY) in… |
DENTSPLY SIRONA (XRAY) Q3 Earnings & Revenues Miss EstimatesDespite a year-over-year decline in both earnings and revenues, DENTSPLY SIRONA's (XRAY) third-quarter results benefit from the Technologies & Equipment business. |
XRAY Price Returns
| 1-mo | 3.18% |
| 3-mo | -5.94% |
| 6-mo | N/A |
| 1-year | -36.00% |
| 3-year | -43.28% |
| 5-year | -51.65% |
| YTD | -42.99% |
| 2021 | 7.32% |
| 2020 | -6.59% |
| 2019 | 53.14% |
| 2018 | -43.00% |
| 2017 | 14.66% |
XRAY Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching XRAY
Want to see what other sources are saying about DENTSPLY SIRONA Inc's financials and stock price? Try the links below:DENTSPLY SIRONA Inc (XRAY) Stock Price | Nasdaq
DENTSPLY SIRONA Inc (XRAY) Stock Quote, History and News - Yahoo Finance
DENTSPLY SIRONA Inc (XRAY) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...